John writes about the politics of health care, and he is the author of the twice-weekly D.C. Diagnosis newsletter. You can reach John on Signal at John_Wilkerson.07. WASHINGTON — Clinical trial policy ...
Palmer is investigating how telehealth is driving the consumerization of drugs. This is Part 6 of the series The VirtualRx Boom. Katie covers the impact of health technology on patients, clinicians, ...
A U.S. Centers for Medicare & Medicaid Services 18-month trial program will offer for the first time Novo Nordisk’s Wegovy ...
Reducing Medicare payments for 340B drugs is the latest proposal focused on the hotly debated drug discount program.
Sources confirm to STAT that Marburg cases have been detected in western Uganda, adding another viral hemorrhagic fever ...
Dozens of congressional lawmakers are urging the Trump administration to force Eli Lilly to reinstate mandated price breaks ...
Elevance Health has sued the U.S. government, alleging that federal efforts to recalculate its Medicare Advantage quality ...
Companies are being too conservative in how they interpret FDA's AI guidance, but the agency can do more to help, too, Tala ...
A federal judge blocked a Colorado state panel from placing a cap on the price of Enbrel, a blockbuster drug sold by Amgen ...
What is urgently needed is a shift from pathogen-specific diagnostics toward pathogen-agnostic diagnostic systems,” write ...
The newly cleared device is based around an app that helps a patient manage their diabetes using a treatment plan defined by ...
This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results